FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200389606> ?p ?o ?g. }

• W4200389606 endingPage "1042" @default.
• W4200389606 startingPage "1036" @default.
• W4200389606 abstract "Hepatitis B vaccination is recommended in all patients with end-stage kidney disease (ESKD). However, only 50-60% of these patients achieve protective antibody levels if immunized after starting dialysis. Strategies to overcome this low seroconversion rate include a 6-month vaccination schedule starting earlier [chronic kidney disease (CKD) stage 4 and 5] to ensure immunity when patients progress to ESKD. We conducted a quality improvement program to immunize pre-dialysis patients. Patients who were found to have a negative baseline serology with a negative hepatitis B surface antibody level (HBsAb) were offered vaccination on a 6-month schedule (0, 1 and 6 months) with one of two available vaccines within the VA system (Recombivax™ or Engerix™). HBsAb titers were checked 3-4 months later, and titers ≥ 12 mIU/mL were indicative of immunity at VA. Patients who did not seroconvert were offered a repeat schedule of three more doses. We screened 198 patients (187 males and 11 females) with CKD 4 and 5 [glomerular filtration rate (GFR) < 29 mL/min/1.73 m2]. The median age of this cohort was 72 years (range 38-92 years). During the study period of 5 years (2015-2020), 10 patients were excluded since their GFR had improved to more than 30 mL/min/1.73 m2, 24 others had baseline immunity and 2 refused vaccination. The hepatitis B vaccination series was not started on 106 patients. Of the remaining 56, 12 patients progressed to ESKD and started dialysis before completion of the vaccination schedule, 6 expired and 1 did not come to clinic in 2020 due to the pandemic. Of the 37 patients who completed the vaccination schedule, 16 achieved seroconversion with adequate HBsAb titers, 10 did not develop immunity despite a second hepatitis B vaccination series, while 11 did not get a second series. Given the low seroconversion rate, albeit in a small cohort, vaccination should be considered in patients with earlier stages of CKD. Other options include studies on FDA approved vaccines of shorter duration. We plan to increase awareness among nephrologists, patients and nursing staff about the importance of achieving immunity against hepatitis B." @default.
• W4200389606 created "2021-12-31" @default.
• W4200389606 creator A5008521002 @default.
• W4200389606 creator A5025051526 @default.
• W4200389606 creator A5054296897 @default.
• W4200389606 creator A5055752959 @default.
• W4200389606 creator A5061533624 @default.
• W4200389606 creator A5068309571 @default.
• W4200389606 creator A5069699129 @default.
• W4200389606 creator A5083526053 @default.
• W4200389606 creator A5091029385 @default.
• W4200389606 date "2021-12-06" @default.
• W4200389606 modified "2023-09-24" @default.
• W4200389606 title "Hepatitis B Vaccination in Advanced Chronic Kidney Disease: A Quality Improvement Project at a Veteran Affairs Chronic Kidney Disease Clinic" @default.
• W4200389606 cites W1966821786 @default.
• W4200389606 cites W1985439784 @default.
• W4200389606 cites W1987380247 @default.
• W4200389606 cites W1997362337 @default.
• W4200389606 cites W2000942682 @default.
• W4200389606 cites W2038932408 @default.
• W4200389606 cites W2088453437 @default.
• W4200389606 cites W2093199542 @default.
• W4200389606 cites W2098382203 @default.
• W4200389606 cites W2104969243 @default.
• W4200389606 cites W2121064129 @default.
• W4200389606 cites W2147024431 @default.
• W4200389606 cites W2149980168 @default.
• W4200389606 cites W2160423624 @default.
• W4200389606 cites W2173855355 @default.
• W4200389606 cites W2463620256 @default.
• W4200389606 cites W2799743288 @default.
• W4200389606 cites W2960287747 @default.
• W4200389606 cites W2986205132 @default.
• W4200389606 cites W3036673532 @default.
• W4200389606 cites W3044628506 @default.
• W4200389606 doi "https://doi.org/10.3390/idr13040094" @default.
• W4200389606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34940404" @default.
• W4200389606 hasPublicationYear "2021" @default.
• W4200389606 type Work @default.
• W4200389606 citedByCount "0" @default.
• W4200389606 crossrefType "journal-article" @default.
• W4200389606 hasAuthorship W4200389606A5008521002 @default.
• W4200389606 hasAuthorship W4200389606A5025051526 @default.
• W4200389606 hasAuthorship W4200389606A5054296897 @default.
• W4200389606 hasAuthorship W4200389606A5055752959 @default.
• W4200389606 hasAuthorship W4200389606A5061533624 @default.
• W4200389606 hasAuthorship W4200389606A5068309571 @default.
• W4200389606 hasAuthorship W4200389606A5069699129 @default.
• W4200389606 hasAuthorship W4200389606A5083526053 @default.
• W4200389606 hasAuthorship W4200389606A5091029385 @default.
• W4200389606 hasBestOaLocation W42003896061 @default.
• W4200389606 hasConcept C126322002 @default.
• W4200389606 hasConcept C159641895 @default.
• W4200389606 hasConcept C159654299 @default.
• W4200389606 hasConcept C203014093 @default.
• W4200389606 hasConcept C22070199 @default.
• W4200389606 hasConcept C2522874641 @default.
• W4200389606 hasConcept C2777382497 @default.
• W4200389606 hasConcept C2777451964 @default.
• W4200389606 hasConcept C2778653478 @default.
• W4200389606 hasConcept C2779978075 @default.
• W4200389606 hasConcept C2780593183 @default.
• W4200389606 hasConcept C2780791431 @default.
• W4200389606 hasConcept C2780801004 @default.
• W4200389606 hasConcept C71924100 @default.
• W4200389606 hasConceptScore W4200389606C126322002 @default.
• W4200389606 hasConceptScore W4200389606C159641895 @default.
• W4200389606 hasConceptScore W4200389606C159654299 @default.
• W4200389606 hasConceptScore W4200389606C203014093 @default.
• W4200389606 hasConceptScore W4200389606C22070199 @default.
• W4200389606 hasConceptScore W4200389606C2522874641 @default.
• W4200389606 hasConceptScore W4200389606C2777382497 @default.
• W4200389606 hasConceptScore W4200389606C2777451964 @default.
• W4200389606 hasConceptScore W4200389606C2778653478 @default.
• W4200389606 hasConceptScore W4200389606C2779978075 @default.
• W4200389606 hasConceptScore W4200389606C2780593183 @default.
• W4200389606 hasConceptScore W4200389606C2780791431 @default.
• W4200389606 hasConceptScore W4200389606C2780801004 @default.
• W4200389606 hasConceptScore W4200389606C71924100 @default.
• W4200389606 hasIssue "4" @default.
• W4200389606 hasLocation W42003896061 @default.
• W4200389606 hasLocation W42003896062 @default.
• W4200389606 hasLocation W42003896063 @default.
• W4200389606 hasLocation W42003896064 @default.
• W4200389606 hasOpenAccess W4200389606 @default.
• W4200389606 hasPrimaryLocation W42003896061 @default.
• W4200389606 hasRelatedWork W1582864768 @default.
• W4200389606 hasRelatedWork W1983097004 @default.
• W4200389606 hasRelatedWork W2066252194 @default.
• W4200389606 hasRelatedWork W2081067572 @default.
• W4200389606 hasRelatedWork W2151318446 @default.
• W4200389606 hasRelatedWork W2277570703 @default.
• W4200389606 hasRelatedWork W2397089454 @default.
• W4200389606 hasRelatedWork W2552096264 @default.
• W4200389606 hasRelatedWork W2802383963 @default.
• W4200389606 hasRelatedWork W4213149189 @default.
• W4200389606 hasVolume "13" @default.
• W4200389606 isParatext "false" @default.

• next